CNTO 2476 ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
90Retinitis pigmentosa1

90. Retinitis pigmentosa


Clinical trials : 130 Drugs : 180 - (DrugBank : 41) / Drug target genes : 49 - Drug target pathways : 109
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00458575
(ClinicalTrials.gov)
April 200710/4/2007A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis PigmentosaA Phase I Open Label Non-comparative Study Evaluating the Safety of a Single, Unilateral, Subretinal Administration of CNTO 2476 in Advanced Retinitis PigmentosaRetinitis PigmentosaDrug: CNTO 2476Centocor, Inc.NULLTerminated18 YearsN/ABoth7Phase 1United States